Treatment of glaucoma in patients with dry eye syndrome

被引：4

作者：

Labbe, A. ^{[1
,2
,3
,4
]}

Baudouin, C. ^{[1
,2
,3
,4
]}

机构：

[1] CHNO Quinze Vingts, Serv Ophtalmol 3, F-75012 Paris, France

[2] Univ Paris 06, INSERM, Inst Vis, UMRS 968, Paris, France

[3] Hop Ambroise Pare, AP HP, Serv Ophtalmol, Boulogne, France

[4] Univ Versailles, Versailles, France

来源：

JOURNAL FRANCAIS D OPHTALMOLOGIE | 2010年 / 33卷 / 04期

关键词：

Glaucoma; Ocular hypertension; Treatment; Dry eye; SELECTIVE LASER TRABECULOPLASTY; TOPICAL ANTIGLAUCOMA MEDICATION; OCULAR SYMPTOMS; PREVALENCE; EYEDROPS; SIGNS;

D O I：

10.1016/j.jfo.2010.02.006

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The treatments of glaucoma or ocular hypertension are associated with numerous ocular surface changes. Similarly, these ocular surface modifications directly impact the effectiveness of these therapies. The management of patients with glaucoma or ocular hypertension also suffering from dry eye syndrome needs to reduce eye drop-induced toxicity as well as a specific treatment for the ocular surface. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：285 / 290

页数：6

共 31 条

[1] DRUG-INDUCED OCULAR PSEUDOPEMPHIGOID [J].